Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maurice M Heimer

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Computer Methods and Programs in Biomedicine|April 1, 2023
Dual center validation of deep learning for automated multi-label segmentation of thoracic anatomy in bedside chest radiographsFelix Busch, Lina Xu, Dmitry Sushko, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|January 20, 2018
<sup>18</sup>F-FDG-PET/CT and diffusion-weighted MRI for monitoring a BRAF and CDK 4/6 inhibitor combination therapy in a murine model of human melanomaRalf S Eschbach, Philipp M Kazmierczak, Maurice M Heimer, et al.
Molecular Imaging and Biology|October 16, 2025
[<sup>18</sup>F]FDG-PET/CT Imaging for Response Characterisation of Experimental Melanomas to Anti-PD-L1/Anti-CTLA-4 ImmunotherapyMelissa J Antons, Sandra Kloiber-Langhorst, Heidrun Hirner-Eppeneder, et al.
Plos One|July 1, 2025
Contrast-enhanced ultrasound with VEGFR2-targeted microbubbles for monitoring combined anti-PD-L1/anti-CTLA-4 immunotherapy effects in a murine melanoma model with immunohistochemical validationFelix L Herr, Melissa J Antons, Larissa V Blume, et al.
EJNMMI Research|August 20, 2025
Predictors of renal function decline in patients with gastroenteropancreatic neuroendocrine tumors undergoing [177Lu]Lu-DOTA-TATE therapyFelix L Herr, Christian Dascalescu, Victoria Fusch, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 27, 2025
PET- and CT-Based Imaging Criteria for Response Assessment of Gastroenteropancreatic Neuroendocrine Tumors Under Radiopharmaceutical TherapyFelix L Herr, Christian Dascalescu, Matthias P Fabritius, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 23, 2025
Artificial intelligence for TNM staging in NSCLC: a critical appraisal of segmentation utility in [<sup>1</sup>⁸F]FDG PET/CTMaurice M Heimer, Jakob Dexl, Johanna Ta, et al.
European Radiology|March 25, 2023
Validation of the SSTR-RADS 1.0 for the structured interpretation of SSTR-PET/CT and treatment planning in neuroendocrine tumor (NET) patientsFreba Grawe, Ricarda Ebner, Thomas Geyer, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|January 24, 2025
Maren Friederike Balks, Nadine Bayerl, Josephine Berger, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|June 8, 2023
Patterns of pseudoprogression across different cancer entities treated with immune checkpoint inhibitorsSebastian Mönch, Maurice M Heimer, Michael Winkelmann, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Computer Methods and Programs in Biomedicine|April 1, 2023
Dual center validation of deep learning for automated multi-label segmentation of thoracic anatomy in bedside chest radiographsFelix Busch, Lina Xu, Dmitry Sushko, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|January 20, 2018
<sup>18</sup>F-FDG-PET/CT and diffusion-weighted MRI for monitoring a BRAF and CDK 4/6 inhibitor combination therapy in a murine model of human melanomaRalf S Eschbach, Philipp M Kazmierczak, Maurice M Heimer, et al.
Molecular Imaging and Biology|October 16, 2025
[<sup>18</sup>F]FDG-PET/CT Imaging for Response Characterisation of Experimental Melanomas to Anti-PD-L1/Anti-CTLA-4 ImmunotherapyMelissa J Antons, Sandra Kloiber-Langhorst, Heidrun Hirner-Eppeneder, et al.
Plos One|July 1, 2025
Contrast-enhanced ultrasound with VEGFR2-targeted microbubbles for monitoring combined anti-PD-L1/anti-CTLA-4 immunotherapy effects in a murine melanoma model with immunohistochemical validationFelix L Herr, Melissa J Antons, Larissa V Blume, et al.
EJNMMI Research|August 20, 2025
Predictors of renal function decline in patients with gastroenteropancreatic neuroendocrine tumors undergoing [177Lu]Lu-DOTA-TATE therapyFelix L Herr, Christian Dascalescu, Victoria Fusch, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 27, 2025
PET- and CT-Based Imaging Criteria for Response Assessment of Gastroenteropancreatic Neuroendocrine Tumors Under Radiopharmaceutical TherapyFelix L Herr, Christian Dascalescu, Matthias P Fabritius, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 23, 2025
Artificial intelligence for TNM staging in NSCLC: a critical appraisal of segmentation utility in [<sup>1</sup>⁸F]FDG PET/CTMaurice M Heimer, Jakob Dexl, Johanna Ta, et al.
European Radiology|March 25, 2023
Validation of the SSTR-RADS 1.0 for the structured interpretation of SSTR-PET/CT and treatment planning in neuroendocrine tumor (NET) patientsFreba Grawe, Ricarda Ebner, Thomas Geyer, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|January 24, 2025
Maren Friederike Balks, Nadine Bayerl, Josephine Berger, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|June 8, 2023
Patterns of pseudoprogression across different cancer entities treated with immune checkpoint inhibitorsSebastian Mönch, Maurice M Heimer, Michael Winkelmann, et al.
Pageof 3